Ardsley Advisory Partners’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,000
| Closed | -$26K | – | 103 |
|
|
2020
Q3 | $26K | Sell |
1,000
-1,000
| -50% | -$26K | 0.01% | 123 |
|
|
2020
Q2 | $146K | Buy |
2,000
+400
| +25% | +$29.2K | 0.03% | 107 |
|
|
2020
Q1 | $84K | Buy |
1,600
+400
| +33% | +$21K | 0.03% | 83 |
|
|
2019
Q4 | $98K | Hold |
1,200
| – | – | 0.02% | 120 |
|
|
2019
Q3 | $68K | Sell |
1,200
-400
| -25% | -$22.7K | 0.02% | 105 |
|
|
2019
Q2 | $190K | Buy |
1,600
+400
| +33% | +$47.5K | 0.03% | 115 |
|
|
2019
Q1 | $221K | Buy |
1,200
+451
| +60% | +$83.1K | 0.04% | 103 |
|
|
2018
Q4 | $134K | Sell |
749
-651
| -47% | -$116K | 0.03% | 86 |
|
|
2018
Q3 | $448K | Buy |
1,400
+400
| +40% | +$128K | 0.06% | 96 |
|
|
2018
Q2 | $400K | Sell |
1,000
-200
| -17% | -$80K | 0.06% | 107 |
|
|
2018
Q1 | $428K | Sell |
1,200
-400
| -25% | -$143K | 0.06% | 96 |
|
|
2017
Q4 | $634K | Sell |
1,600
-400
| -20% | -$159K | 0.08% | 76 |
|
|
2017
Q3 | $853K | Sell |
2,000
-400
| -17% | -$171K | 0.11% | 64 |
|
|
2017
Q2 | $383K | Buy |
2,400
+600
| +33% | +$95.8K | 0.06% | 87 |
|
|
2017
Q1 | $224K | Buy |
1,800
+200
| +13% | +$24.9K | 0.03% | 107 |
|
|
2016
Q4 | $194K | Buy |
1,600
+800
| +100% | +$97K | 0.03% | 106 |
|
|
2016
Q3 | $120K | Buy |
+800
| New | +$120K | 0.02% | 132 |
|